Women's Health News

RSS

Also in Global Health News: HIV/AIDS in Central Asia; Nigeria MDGs; Aid transparency; Maternal health in Peru

Aljazerra.net reports on the spread of HIV/AIDS throughout Central Asia along drug routes in the region. The piece examines the lack of information available to the people of Central Asia about HIV prevention strategies and a recent effort among a group of Muslim imams in Tajikistan to educate people about the disease (Andersen, 3/31).

1 Apr 2010

Family planning, access to safe, legal abortion key to maternal, child health, U.S. Sec. of State says

Following a two-day meeting of foreign ministers from G8 countries in Quebec on Tuesday, Secretary of State Hillary Rodham Clinton "appeared at odds … with [Canadian] Prime Minister Stephen Harper's G8 initiative on maternal and child health, saying family planning, contraception and access to legal, safe abortions were vital elements of maternal health care," Canwest News Service/Ottawa Citizen report (O'Neill, 3/31).

1 Apr 2010

Link between occupational exposures and postmenopausal breast cancer

Occupational exposure to certain chemicals and pollutants before a woman reaches her mid-30s could treble her risk of developing cancer after the menopause, suggests research published in Occupational and Environmental Medicine .

1 Apr 2010

Structured and supervised exercise can prevent postnatal depression, says study

Postnatal depression (PND) or baby blues are a recognized entity with millions of mothers suffering from it in varying degrees. It affects 13% of the new mothers usually within the first 3 months after the birth of the baby.

1 Apr 2010

Breastfeeding benefits expanded to cover mothers: Risk of diabetes reduced

Research has found a new benefit that mothers can obtain by breast feeding – decreased risk of type 2 diabetes. Benefits of breastfeeding for the baby have been cited for a long time now. In spite of this knowledge according to The Australian Breastfeeding Association there is a definite gap in awareness regarding health benefits that this simple yet effective practice can offer.

1 Apr 2010

VIVUS terminates Luramist development, commercialization agreement with FemPharm

VIVUS, Inc. today announced that it has terminated the Development and Commercialization Agreement with FemPharm Pty Ltd. (a wholly owned subsidiary of Acrux Limited) for Luramist™, a metered dose transdermal application of testosterone for women.

1 Apr 2010

Court rules against gene patents

The New York Times: A judicial ruling that "threw out parts of two gene patents and called into question thousands more" has biotechnology executives hastening "to reassure their investors that the ruling would not necessarily undermine their businesses, at least in the short run. But the executives themselves were struggling on Tuesday to figure out what the long-term impact would be."

1 Apr 2010

Eisai Europe seeks EMA approval of eribulin mesylate for locally advanced or metastatic breast cancer

Eisai Europe Ltd. today announced that it has submitted a marketing authorization application to the European Medicines Agency (EMA) for approval of eribulin mesylate, also known as 'E7389', for the treatment of locally advanced or metastatic breast cancer in Europe. Eribulin mesylate, a non-taxane microtubule dynamics inhibitor, is an investigational chemical compound discovered and developed by Eisai. Regulatory applications for eribulin mesylate have also been submitted in the United States and Japan.

31 Mar 2010

Fourth biennial BHGI Global Summit on International Breast Health

The Breast Health Global Initiative and the Latin American & Caribbean Society of Medical Oncology will convene the fourth biennial BHGI Global Summit on International Breast Health June 9-11, 2010 in Chicago, bringing together collaborating national and international organizations to address the optimization of breast health care delivery in limited-resource countries.

31 Mar 2010

Benefits outweigh risks associated with breast cancer screening

FOR EVERY woman overdiagnosed by breast screening, two deaths will be prevented, according to a study published today (Wednesday).

31 Mar 2010

Study finds groundbreaking technology in TechniScan's Warm Bath Ultrasound promising

TechniScan, Inc.'s unique whole breast ultrasound technology, which provides a comfortable, radiation-free method for assessment of breast lesions was part of a scientific presentation at the National Consortium of Breast Centers (NCBC) conference in Las Vegas last week.

31 Mar 2010

Guided Therapeutics' LightTouch Cervical Scanner demonstrates increased detection of disease over Pap tests

The Guided Therapeutics, Inc. LightTouch™ Cervical Scanner increased detection of significant disease over Pap tests in women seen in a busy private practice setting, according to results of a U.S. Food and Drug Administration pivotal clinical trial presented at the American Society for Colposcopy and Cervical Pathology biennial meeting.

31 Mar 2010

March of Dimes declares 2010 Colorado funding for mom and baby health programs

The March of Dimes today announced its 2010 Colorado funding for mom and baby health programs. In total, the organization will invest $1,959,227 in research, services, education and advocacy programs.

31 Mar 2010

PMDD often misdiagnosed as major depression or other mood disorder

As science slowly, but continually, unravels the causes of disorders, it increasingly teases apart biological threads that, when spooled together, begin to take on the warp and weft of separate disorders.

31 Mar 2010

Eisai seeks simultaneous approval of eribulin mesylate in U.S., EU and Japan

Eisai Inc. today announced that it has submitted simultaneous regulatory applications for approval of eribulin mesylate (also known as E7389) for the treatment of locally advanced or metastatic breast cancer to agencies in Japan, the United States and the European Union (EU). Eribulin, a non-taxane microtubule dynamics inhibitor, is an investigational chemical compound discovered and developed by Eisai.

31 Mar 2010

Devicor offers to acquire EES Breast Care business

Ethicon Endo-Surgery, Inc. (EES), a Johnson & Johnson company, today announced it has received an irrevocable, unconditional offer from Devicor Medical Products (Devicor), a portfolio company of GTCR Golder Rauner, LLC, (GTCR), to acquire its Breast Care business. The EES Breast Care business sells products designed to help doctors diagnose breast cancer at early stages, while minimizing patient discomfort. Financial terms of the offer are not being disclosed.

31 Mar 2010

Beta-blockers can reduce cancer spread in patients with breast tumours

The risk of cancer spreading in patients with breast tumours can be lowered with the use of beta-blockers, research presented at the European Breast Cancer Conference in Barcelona suggests.

31 Mar 2010

Study indicates estrogenic drug could help treat schizophrenia

An estrogenic drug that influences neurotransmitter and neuronal systems in the brain is showing promise as an effective therapy for women who suffer from schizophrenia.

31 Mar 2010

Study evaluates OCP treatment to prevent endometrioma recurrence

Ovarian endometriomas, better known as ovarian 'chocolate' cysts for the brown liquid they contain, can be easily removed by surgery. However, recurrence is common, which can cause ongoing pain and complications. A study evaluated for Faculty of 1000 suggests a simple and effective remedy - the oral contraceptive pill.

31 Mar 2010

Facts and treatment options for endometriosis

One out of every two women struggling to conceive may suffer from endometriosis - the leading cause of infertility - according to research from Camran Nezhat, M.D., gynecologist at El Camino Hospital, the hospital of the Silicon Valley.

31 Mar 2010